1. Home
  2. PCN vs ABCL Comparison

PCN vs ABCL Comparison

Compare PCN & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCN
  • ABCL
  • Stock Information
  • Founded
  • PCN 2001
  • ABCL 2012
  • Country
  • PCN United States
  • ABCL Canada
  • Employees
  • PCN N/A
  • ABCL N/A
  • Industry
  • PCN Investment Managers
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • PCN Finance
  • ABCL Health Care
  • Exchange
  • PCN Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • PCN 800.4M
  • ABCL 772.9M
  • IPO Year
  • PCN N/A
  • ABCL 2020
  • Fundamental
  • Price
  • PCN $12.57
  • ABCL $3.41
  • Analyst Decision
  • PCN
  • ABCL Strong Buy
  • Analyst Count
  • PCN 0
  • ABCL 4
  • Target Price
  • PCN N/A
  • ABCL $8.33
  • AVG Volume (30 Days)
  • PCN 218.7K
  • ABCL 6.1M
  • Earning Date
  • PCN 01-01-0001
  • ABCL 08-05-2025
  • Dividend Yield
  • PCN 9.73%
  • ABCL N/A
  • EPS Growth
  • PCN N/A
  • ABCL N/A
  • EPS
  • PCN N/A
  • ABCL N/A
  • Revenue
  • PCN N/A
  • ABCL $23,114,000.00
  • Revenue This Year
  • PCN N/A
  • ABCL N/A
  • Revenue Next Year
  • PCN N/A
  • ABCL $66.89
  • P/E Ratio
  • PCN N/A
  • ABCL N/A
  • Revenue Growth
  • PCN N/A
  • ABCL N/A
  • 52 Week Low
  • PCN $10.70
  • ABCL $1.89
  • 52 Week High
  • PCN $14.48
  • ABCL $3.68
  • Technical
  • Relative Strength Index (RSI)
  • PCN 40.89
  • ABCL 76.76
  • Support Level
  • PCN $12.46
  • ABCL $3.10
  • Resistance Level
  • PCN $12.61
  • ABCL $3.57
  • Average True Range (ATR)
  • PCN 0.09
  • ABCL 0.25
  • MACD
  • PCN -0.02
  • ABCL 0.10
  • Stochastic Oscillator
  • PCN 30.00
  • ABCL 89.68

About PCN Pimco Corporate & Income Strategy Fund

PIMCO Corporate & Income Strategy Fund is a closed-end management investment company. Its objective is to seek high current income with capital appreciation as a secondary objective. It invests in corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, short-term instruments, and others.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: